uce
ProgressImage ProgressImage
Concord Drugs Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 538965 border-img ISIN Demat INE858L01010 border-img Book Value 34.11 border-img NSE Symbol N.A border-img Div & Yield % 0 border-img Market Cap ( Cr.) 68.6 border-img P/E 171.5 border-img EPS 0.4 border-img Face Value 10
Quarters
ParticularsJun 2025
()
Mar 2025
()
Dec 2024
()
Gross Sales13.387.9610.77
Other Operating Income0.000.000.00
Other Income 0.000.000.00
Total Income13.387.9710.77
Total Expenditure 12.457.049.46
PBIDT0.940.931.31
Interest 0.420.530.43
PBDT0.520.400.89
Depreciation0.370.370.37
Tax0.05-0.010.14
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.010.020.16
Reported Profit After Tax0.110.010.22
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.110.010.22
    
EPS (Unit Curr.)0.110.010.22
EPS (Adj) (Unit Curr.)0.110.010.22
Calculated EPS (Unit Curr.)0.110.010.22
Calculated EPS (Adj) (Unit Curr.)0.110.010.22
Calculated EPS (Ann.) (Unit Curr.)0.450.030.89
Calculated EPS (Adj) (Ann.) (Unit Curr.)0.450.030.89
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.0010.0010.00
Reserve & Surplus24.2324.1124.11
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)7.0311.6812.16
PBDTM(%)3.895.038.26
PATM(%)0.820.132.04
x
x
×
Let's Chat
close
refresh